Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1784-1789

  Spijkerman, Annemieke M W ^a,b   Adriaanse, Marcel C ^a   Dekker, Jacqueline M ^a   Nijpels, Giel ^a   Stehouwer, Coen D A ^a,b   Bouter, Lex M ^a   Heine, Robert J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POPULATION; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETIC ANGIOPATHY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PATHOPHYSIOLOGY; RISK FACTOR;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LIPOPROTEINS, HDL; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; RISK FACTORS; TRIGLYCERIDES;

EID: 0036782360     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1784     Document Type: Article

References (25)

1. American Diabetes Association: Screening for diabetes (Position Statement). Diabetes Care 23 (Suppl. 1):S20-S23, 2000
2. Clark CM, Fradkin JE, Hiss RG, Lorenz RA, Vinicor F, Warren-Boulton E: Promoting early diagnosis and treatment of type 2 diabetes: the National Diabetes Education Program. JAMA 284:363-365, 2000
3. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, Heine RJ: Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 18:1270-1273, 1995
4. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
5. UK Prospective Diabetes Study 6: Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 13:1-11, 1990
6. Engelgau MM, Narayan KM, Herman WH: Screening for type 2 diabetes. Diabetes Care 23:1563-1580, 2000
7. Lawrence JM, Bennett P, Young A, Robinson AM: Screening for diabetes in general practice: cross sectional population study. BMJ 323:548-551, 2001
8. Claudi T, Midthjell K, Holmen J, Fougner K, Kruger O, Wiseth R: Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: the Nord-Trondelag Diabetes Study, Norway. J Intern Med 248:492-500, 2000
9. Leiter LA, Barr A, Belanger A, Lubin S, Ross SA, Tildesley HD, Fontaine N: Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care 24:1038-1043, 2001
10. Bullimore SP, Keyworth C: Finding diabetics: a method of screening in general practice. Br J Gen Pract 47:371-374, 1997
11. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ: Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491-496, 1997
12. Ashworth L, Gibb I, Alberti KG: HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem 38:1479-1482, 1992
13. Voss EM, Cembrowski GS: Performance characteristics of the HemoCue B-Glucose analyzer using whole-blood samples. Arch Pathol Lab Med 117:711-713, 1993
14. Rutten GEHM, Verhoeven S, Heine RJ, De Grauw WJC, Cromme PVM, Reenders K, Van Ballegooie E, Wiersma TJ: NHG-standaard diabetes mellitus type 2 (eerste herziening). Huisarts Wet 42:67-84, 1999
15. Alberti KGMM, Zimmet PZ: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
16. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K: Prevention of coronary heart disease in clinical practice: recommendations of the Second joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J 19:1434-1503, 1998
17. World Health Organization: Physical Status: the Use and Interpretation of Anthropometry: Report of the WHO Expert Committee. Geneva, World Health Org., 1995 (Tech. Rep. Ser., no. 854)
18. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens 17:151-183, 1999
19. Hillier TA, Pedula KL: Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522-1527, 2001
20. MRC/BHF Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 20:725-741, 1999
21. Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E: Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the Cholesterol and Recurrent Events (CARE) trial. Circulation 98:2513-2519, 1998
22. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
23. Stewart-Brown S, Farmer A: Screening could seriously damage your health. BMJ 314:533-534, 1997
24. Wareham NJ, Griffin SJ: Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 322:986-988, 2001
25. O'Connor PJ, Rush WA, Cherney LM, Pronk NP: Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. Eff Clin Pract 4:271-277, 2001